Xiaoyan, D., Zhang, W., Teng, Y., Du, C., Qiao, W., Jin, R., Chen, J., Huang, Z., Jiang, Z., Yang, L., Zhang, Y., Zhao, D., Zhou, H., Chi, Y., He, S., Ying, J., Sun, Y., Hu, C., Zhao, H. (2026). Phase 1 trial of a KRAS G12V/HLA-A*11:01–restricted TCR-engineered T-cell therapy in advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2542